Hims & Hers Health Inc
NYSE:HIMS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.22
27.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hims & Hers Health Inc
Wall Street
Price Targets
HIMS Price Targets Summary
Hims & Hers Health Inc
According to Wall Street analysts, the average 1-year price target for
HIMS
is 25.74 USD
with a low forecast of 18.18 USD and a high forecast of 33.6 USD.
HIMS Last Price Targets
Hims & Hers Health Inc
The latest public price target was made on Nov 5, 2024 by
Ryan MacDonald
from
Needham
,
who expects
HIMS
stock to
rise by 11%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Ryan MacDonald
Needham
|
28
USD
Upside 11% |
2 weeks ago
Nov 5, 2024
|
Hims and Hers (HIMS) PT Raised to $28 at Needham
StreetInsider
|
Korinne Wolfmeyer
Piper Sandler
|
21
USD
Downside 17% |
2 weeks ago
Nov 5, 2024
|
Hims and Hers (HIMS) PT Raised to $21 at Piper Sandler
StreetInsider
|
|
Michael Cherny
Leerink Partners
|
26
USD
Upside 3% |
3 weeks ago
Oct 29, 2024
|
Hims and Hers (HIMS) PT Raised to $26 at Leerink Partners
StreetInsider
|
Michael Cherny
Bank of America Securities
|
25
USD
Downside 1% |
1 month ago
Oct 21, 2024
|
Hims and Hers (HIMS) PT Raised to $25 at BofA Securities
StreetInsider
|
|
Michael Cherny
Bank of America Securities
|
23
USD
Downside 9% |
1 month ago
Oct 14, 2024
|
Hims and Hers (HIMS) PT Raised to $23 at BofA Securities
StreetInsider
|
Jailendra Singh
Truist Financial
|
23
USD
Downside 9% |
1 month ago
Oct 14, 2024
|
Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
StreetInsider
|
|
Allen Lutz
Bank of America Securities
|
20
USD
Downside 21% |
2 months ago
Sep 13, 2024
|
Hims & Hers price target lowered to $20 from $24 at BofA
TheFly
|
Daniel Grosslight
Citigroup
|
20
USD
Downside 21% |
2 months ago
Aug 27, 2024
|
Citi on Hims and Hers (HIMS) Post Lilly (LLY) News: 'Single-dose Zepbound Vials a Shot Across the Bow for the Compounders'
StreetInsider
|
Glen Santangelo
Jefferies
|
18
USD
Downside 29% |
3 months ago
Aug 7, 2024
|
Hims and Hers (HIMS) PT Lowered to $18 at Jefferies
StreetInsider
|
George Hill
Deutsche Bank
|
23
USD
Downside 9% |
3 months ago
Aug 6, 2024
|
Hims and Hers (HIMS) PT Raised to $23 at Deutsche Bank
StreetInsider
|
Maria Ripps
Canaccord Genuity
|
24
USD
Downside 5% |
6 months ago
May 22, 2024
|
Hims and Hers (HIMS) PT Raised to $24 at Canaccord Genuity
StreetInsider
|
|
Korinne Wolfmeyer
Piper Sandler
|
13
USD
Downside 49% |
6 months ago
May 7, 2024
|
Hims and Hers (HIMS) PT Raised to $13 at Piper Sandler
StreetInsider
|
|
Jailendra Singh
Truist Financial
|
13
USD
Downside 49% |
6 months ago
May 7, 2024
|
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
Benzinga
|
|
George Hill
Deutsche Bank
|
16
USD
Downside 37% |
6 months ago
May 7, 2024
|
Hims and Hers (HIMS) PT Raised to $16 at Deutsche Bank
StreetInsider
|
|
Glen Santangelo
Jefferies
|
14
USD
Downside 45% |
6 months ago
May 7, 2024
|
Hims and Hers (HIMS) PT Lowered to $14 at Jefferies
StreetInsider
|
|
Glen Santangelo
Jefferies
|
15
USD
Downside 41% |
7 months ago
Apr 16, 2024
|
Jefferies Downgrades Hims and Hers (HIMS) to Hold
StreetInsider
|
|
Maria Ripps
Canaccord Genuity
|
20
USD
Downside 21% |
7 months ago
Apr 10, 2024
|
Canaccord Genuity Starts Hims and Hers (HIMS) at Buy, 'we see a healthy long-term opportunity'
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HIMS's stock price target?
Price Target
25.74
USD
According to Wall Street analysts, the average 1-year price target for
HIMS
is 25.74 USD
with a low forecast of 18.18 USD and a high forecast of 33.6 USD.
What is Hims & Hers Health Inc's Revenue forecast?
Projected CAGR
40%
The
compound annual growth rate
of Hims & Hers Health Inc's revenue for the next 3 years is
40%.
You don't have any saved screeners yet
